Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3FM0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,556
Award facts
- Contract value 100% obligated
- $16,556.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,556.41 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick autoinjector pens. This non-set-aside, competitively awarded contract operates under a firm fixed-price structure with an ultimate completion date of January 13, 2026. The award represents a task order issued against AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which carries a ceiling value of $999,999,999.00 and extends through December 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Repatha is a prescription medication used in the management of high cholesterol and cardiovascular disease prevention. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and supplies pharmaceutical products across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's extensive portfolio of federal contract awards demonstrates its capability to efficiently fulfill government requirements for essential pharmaceutical and medical commodities through open competition on a full and open basis.
Quick answers
Who was awarded contract SPE2DR26F3FM0?
SPE2DR26F3FM0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26F3FM0 worth?
The government has obligated $16,556 on SPE2DR26F3FM0.
Is contract SPE2DR26F3FM0 an order under another contract?
Yes. SPE2DR26F3FM0 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FM0 competed?
The extent of competition for SPE2DR26F3FM0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award